We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-17.73%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$28.2B
AUM Growth
-$5.12B
Cap. Flow
+$1.59B
Cap. Flow %
5.63%
Top 10 Hldgs %
51.6%
Holding
2,190
New
189
Increased
631
Reduced
877
Closed
327
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTD icon
1701
PUT
Trade Desk
TTD
$8.13B
$25K ﹤0.01%
+4,000
New +$104K
RLH
1702
DELISTED
Red Lions Hotel Corporation
RLH
$25K ﹤0.01%
17,000
TTOO
1703
DELISTED
T2 Biosystems, Inc
TTOO
$24K ﹤0.01%
8
+5
+167% +$20.8K
TSLA icon
1704
PUT
Tesla
TSLA
$1.24T
$22K ﹤0.01%
19,500
-34,500
-64% -$1.43M
SIEN
1705
DELISTED
Sientra, Inc.
SIEN
$22K ﹤0.01%
1,120
-345
-24% -$18K
STON
1706
DELISTED
StoneMor Inc.
STON
$22K ﹤0.01%
21,081
CRM icon
1707
PUT
Salesforce
CRM
$134B
$21K ﹤0.01%
+1,000
New +$171K
MNDO icon
1708
Mind CTI
MNDO
$20.6M
$21K ﹤0.01%
12,000
-4,385
-27% -$10.5K
SND icon
1709
Smart Sand
SND
$200M
$21K ﹤0.01%
+20,100
New +$33.9K
XYZ
1710
CALL
Block Inc
XYZ
$45.9B
$21K ﹤0.01%
7,500
+5,500
+275% +$376K
VIRX
1711
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$21K ﹤0.01%
+1,429
New +$31K
NDP
1712
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
$21K ﹤0.01%
+2,250
New +$54.2K
ZEN
1713
PUT
DELISTED
ZENDESK INC
ZEN
$21K ﹤0.01%
+2,500
New +$195K
CLDX icon
1714
Celldex Therapeutics
CLDX
$2.77B
$20K ﹤0.01%
12,147
HBM icon
1715
Hudbay
HBM
$9.92B
$20K ﹤0.01%
10,630
+630
+6% +$1.74K
CRM icon
1716
CALL
Salesforce
CRM
$134B
$19K ﹤0.01%
1,700
+900
+113% +$154K
HD icon
1717
PUT
Home Depot
HD
$332B
$19K ﹤0.01%
800
-1,000
-56% -$220K
CPE
1718
DELISTED
Callon Petroleum Company
CPE
$19K ﹤0.01%
3,442
-8,004
-70% -$197K
SRNE
1719
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$19K ﹤0.01%
+10,130
New +$29.2K
ABBV icon
1720
CALL
AbbVie
ABBV
$458B
$18K ﹤0.01%
1,200
+600
+100% +$51.1K
ISRG icon
1721
CALL
Intuitive Surgical
ISRG
$121B
$18K ﹤0.01%
+1,200
New +$220K
LSTA icon
1722
Lisata Therapeutics
LSTA
$15.2M
$18K ﹤0.01%
672
-1
-0.1% -$39
MVIS icon
1723
Microvision
MVIS
$88.2M
$18K ﹤0.01%
+106,000
New +$52.5K
NXE icon
1724
NexGen Energy
NXE
$6.05B
$18K ﹤0.01%
25,400
ARKK icon
1725
CALL
ARK Innovation ETF
ARKK
$5.89B
$17K ﹤0.01%
+36,000
New +$1.84M

Similar funds

Creative Planning's Q1 2020 Portfolio in Review

As of Q1 2020, Creative Planning held 2,190 positions worth $28.2B, down 15% from $33.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Creative Planning deployed $1.59B of net new capital in Q1 2020, opening 189 new positions and adding to 631 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 6,488,646 shares worth $288M.

By sector, the portfolio is most concentrated in Technology at 4.7% of assets, down from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $778M trimmed.

  • Creative Planning's largest Q1 2020 buy was iShares Core MSCI International Developed Markets ETF: 6,488,646 shares worth $288M.
  • Creative Planning added most to Vanguard Total Stock Market ETF in Q1 2020, an estimated $1.07B increase.
  • Creative Planning's biggest Q1 2020 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $778M.
  • Creative Planning fully exited ETRACS Monthly Pay 2xLeveraged Mortgage REIT ETN Series B due October 16, 2042 in Q1 2020, selling an estimated $7.3M.
  • Creative Planning's ten largest holdings make up 52% of its $28.2B portfolio in Q1 2020.
  • Creative Planning opened 189 new positions and closed 327 in Q1 2020.
  • Creative Planning's portfolio value fell 15% quarter-over-quarter to $28.2B.

Based on Creative Planning's 13F filing for Q1 2020, filed 5 May 2020.